#USA #Atlanta #Surgical Innovations #LevaLap 1.0 #CAST Surgical

CAST Surgical's Clinical Breakthrough

Core Access Surgical Technologies, Inc. (CAST) has made an important stride in the realm of minimally invasive surgery. The company proudly announces that its latest clinical trial manuscript concerning the LevaLap™ 1.0 device has received acceptance for publication in the Journal of the Society of Laparoscopic and Robotic Surgeons (JSLS). This esteemed journal is recognized as a premier outlet for research and advancement in laparoscopic practices and robotic surgery innovations.

With the ongoing emergence and utilization of the LevaLap™ 1.0 across operating rooms worldwide, this clinical study presents compelling evidence of its effectiveness, bolstering interest and adoption rates among surgeons, advanced practitioners, and key opinion leaders in the field. The published manuscript, along with detailed study results, will now be available in PubMed, further enhancing accessibility for medical professionals.

Enhanced Surgical Methods

The study sheds light on the post-market clinical follow-up of the LevaLap™ 1.0 during laparoscopic access, reinforcing its benefits even among seasoned surgeons. Dr. Ricardo Azziz, the study's corresponding author, emphasized, "The results clearly indicate that the LevaLap™ 1.0 device brings significant advantages. It enhances ease of use, improves control, increases speed, and bolsters safety when accessing the abdomen with the Veress needle during minimally invasive surgeries."

This critical feedback underlines the device's relevance, especially considering the vast number of professionals globally who perform similar surgical procedures, irrespective of their experience level.

Acknowledgments to JSLS

CAST extends its heartfelt gratitude to the JSLS for providing a credible platform for the dissemination of their findings. The journal plays a vital role in pushing the boundaries of minimally invasive surgical methods by encouraging scientific collaboration and knowledge exchange. CAST is delighted to contribute to the global mission of improving surgical outcomes through comprehensive research.

Emphasis on Global Standards

Thomas A. Gordy, Chairman and Chief Executive Officer of CAST, remarked, "This publication marks a significant milestone in the global standardization of the Veress Needle access technique in laparoscopic surgery using the LevaLap™ 1.0 device. The multicenter, multi-national study involved diverse surgeons with various access techniques, proving the versatility, safety, efficacy, and ease of adoption of the LevaLap™. This advancement promotes enhanced surgical outcomes and aims to standardize laparoscopic access postures."

About CAST Surgical

CAST is a leading medical device company headquartered in the United States, specializing in the design, development, manufacturing, and distribution of laparoscopic surgery access tools. Their mission is to offer precise, risk-mitigating, and timely access solutions that deliver unique clinical and economic value. Their innovations focus on providing superior alternatives for the medical community. Prospective customers and interested readers can discover more about their products on www.castsurgical.com.

About JSLS

The Journal of the Society of Laparoscopic and Robotic Surgeons (JSLS) is amongst the top-rated peer-reviewed journals dedicated to the niche field of minimally invasive surgery. The publication consistently ranks within the top 1% of over 16,000 scientific journals on PubMed Central in terms of full-text downloads, indicating its popularity and significant engagement with the medical community.

For additional information regarding investor inquiries, contact Thomas A. Gordy at [email protected]. For media inquiries, please reach out via CAST Surgical's hotline at +1-770-328-6642.

This groundbreaking recognition from JSLS serves as both a validation of CAST's ongoing work and a motivation to further enhance laparoscopic surgical techniques worldwide.